Invention Grant
- Patent Title: Modulation of hepatitis B virus (HBV) expression
-
Application No.: US14793622Application Date: 2015-07-07
-
Publication No.: US09677076B2Publication Date: 2017-06-13
- Inventor: Eric E. Swayze , Susan M. Freier , Michael L. McCaleb
- Applicant: Ionis Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: Ionis Pharmaceuticals, Inc. Patent Dept.
- Main IPC: C12N15/113
- IPC: C12N15/113
Abstract:
Disclosed herein are antisense compounds and methods for decreasing HBV mRNA, DNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate HBV-related diseases, disorders or conditions.
Public/Granted literature
- US20160046945A1 MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION Public/Granted day:2016-02-18
Information query
IPC分类:
